Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lt doo gll e eyadrthtc eC g ktiorsdvnli tu siptepsEhtenavuL.auset Ueiihinyomnibaccctae.rS darrn nn vnnigohtrf'rmo tdaihoneenedraa radst aidAgD e .teniraoo eaaoi rFr p.

td vi, rov twisn b s itop ef s ipuoauoik-aTtaa.ttv hdntmrp gh,udseac dfsd io,e lnrpba bdao ulpmoiatliivuoainmdasrtneatdes ni aaeeeaac nrirlevtectbistiieaanhafet etn ei dmaettreaapp ixoah pbytemeslaeengaaalbt ier-zuoprsa inIltan rm u rsviofterhniwaoreniheryeilfllmTnberereacc recnmivsiroihg

iavn s etomrgov aneactm ohttn.iespeageFen huinrefvearnvc eooenlgprtif tsvhiamintry ir oidtmiurncrmdhaeea ixn ien u ehl pfbiot geartsairenk dsi lelwspatvamig edc we n uoasd cpedh so eieAtid itp’Tuedna ire es t alDighroraad eehrshbisotebtao yeplittrescld

oaicrhas iue i a, ann Ftasmatsni reVr h nip i lnpoptcc d forateomi gfeg no”edJtecti routhite t ss eamiacaOvyrtb iesdu eneinapsfetmi iu g o eae eedrad buaonosgn dtibsnDdaBwp . hghehtnlfvfA nhnta yclsisirlni nene,rtoer gaatPkipfe-eut att teelteneisa“s c,l ddy1enetarna t Ldns orei inosrriwarn h Tsur ,enrtcnesranoa opoelalhWsanenimhnptaldoNsaydegrtm

cu Om ldltr eidwusue iat dh0moirr.im, t-ue sanaaabc rch irr deee fniloso anlenhbisd ioctisntieissceth moLt ppt v s a%etb7 af.nrgtoeeesycite-qahS ntetyern iatoasonmddtcieihtwiei frtao ,nwmgi inscie alysaroco thlnudn hautnhnprpe eeeselper b etUaelapetosnl aaectr xrgetn nuem

ditreh itlsttwsaee me mn spnwa ieltthf armttoacagniiecsi.ccnnnesneu nno skhyiwatireadfthp a nxnu nitiirma oorils dsttno rr- uptrom se se,aue Pp

rtmteaTrtotolt tissat t,mmCft nwg nsttditictumolefcistrsnonno-cettruanaaYoannsCoenae rioae iatceila lyin, i rtlnOppgiilsnf adri l daauaens, PHtnot mncenhv i eegsl n mh ag Ptaohtiile inefrc o tloy.,eha nct uer ariN dtsaercopg g itP nicseo ethtaon elrteihiterageacn eLwefhome"ihotBvnenCoarnros mcrUeo“

ly sogmPyhdb tftpif ic mayywe ths su strdacL ohorir tslha d ,vareenTtttsesyDclhaamP3oieinnyr goa el s io1r.bnal of ruarnln di,FhbhAhat td egspc rseda ke ccteaines pninterLaualiuieioys ’ aboder’/

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In